Positron Emission Tomography News and Research

RSS

Cell phone use and the brain: Study

Experts are still grappling with facts and fiction regarding brain damage caused by cell phone use. Dr. Nora Volkow, who is lead author of a new study published in the Feb. 23 issue of the Journal of the American Medical Association said, “We don’t know whether this is detrimental or whether it could have some potential beneficial effects.

22 Feb 2011

Combined chemotherapy and radiation therapy effective against Hodgkin's lymphoma, in the short term

Modern treatment for early stage Hodgkin's lymphoma is highly effective, leaving most patients with no evidence of cancer. However, experts differ on the best approach: Is chemotherapy enough or does adding radiation therapy improve the outcome?

16 Feb 2011

53 share a needle & HIV risk due to a clinic blunder

Over 50 patients at a private radiology clinic were given blood tests using a needle device meant for single-patient use. Authorities have launched an investigation into the matter. These patients are all at risk of hepatitis B, hepatitis C and HIV infection. These cancer patients will need testing for the viruses, and again in three months. They had visited the hospital for a positron emission tomography (PET) scan for cancer detection.

13 Feb 2011

New facilities for developing imaging tests in PESA CNIC-Santander study inaugurated

Felipe P-triz, Secretary of State for Research and Emilio Bot-n, president of Banco Santander have inaugurated today in Banco Santander Finantial City (located in Boadilla del Monte) the new facilities for developing the first imaging tests included in PESA (Progression of Early Subclinical Atherosclerosis) CNIC-Santander study.

8 Feb 2011

FDA clears new mobile radiology application

A new mobile radiology application cleared today by the U.S. Food and Drug Administration will allow physicians to view medical images on the iPhone and iPad manufactured by Apple Inc.

4 Feb 2011

PET imaging may play a role in early evaluation of vandetanib response in thyroid cancer

Positron emission tomography can image metabolic changes following treatment with the protein kinase inhibitor vandetanib, helping to define the therapy response or the effectiveness of the therapeutic agent, according to research published in the February issue of The Journal of Nuclear Medicine.

1 Feb 2011

Taiwanese research team develops large-scale proactive cancer treatment system first-generation prototype

A Taiwanese research team, led by Prof. Ming-Shing Young of Department of Electrical Engineering at National Cheng Kung University (NCKU), has successfully developed a large-scale proactive cancer treatment system first-generation prototype which includes Frequency-Adjustable High Frequency Induction Heating Machine (HFIHM) and 3D Magnetically Guiding Endoscope System (3DMGES).

25 Jan 2011

SNM commends FDA Advisory Committee recommendation for florbetapir approval

The Society of Nuclear Medicine (SNM) commends the U.S. Food and Drug Administration's (FDA) Peripheral and Central Nervous System Drugs Advisory Committee on its recent recommendation for conditional approval of a new imaging agent, florbetapir.

25 Jan 2011

MedImmune announces MEDI-573 preclinical results against many solid tumors

MedImmune's Oncology group announced today preclinical results showing that MEDI-573, a targeted monoclonal antibody, broadly suppresses pathways that have been shown to play a critical role in the development and progression of many solid tumors.

21 Jan 2011

No robust conclusions possible on advantages or disadvantages of PET

Malignant gliomas are fast-growing brain tumours with poor prospects of recovery depending on disease stage. Experts hope that the examination of patients by means of positron emission tomography (PET) is more helpful in the choice of the right treatment than other procedures. In a final report the German Institute for Quality and Efficiency in Health Care (IQWiG) has now investigated the benefit of PET in the detection of recurrences. According to this report, no robust conclusions are possible on the advantages or disadvantages of PET.

20 Jan 2011

Bupropion and varenicline help curb cigarette craving

The smoking cessation medications bupropion and varenicline may both be associated with changes in the way the brain reacts to smoking cues, making it easier for patients to resist cravings, according to two reports posted online today that will appear in the May print issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

4 Jan 2011

18F-FDG PET scans help evaluate cognitive dysfunction of pediatric fever-induced epilepsy

Sudden, catastrophic childhood epilepsy is a parent's worst nightmare, especially in the case of fever-induced refractory epileptic encephalopathy in school-age children (FIRES). While not much is known about the condition, new research published in the January issue of The Journal of Nuclear Medicine shows that positron emission tomography (PET) scans can offer an evaluation of cognitive dysfunction of FIRES, its evolution and further prognosis.

4 Jan 2011

New ATS guidelines for treating fungal infection in adult pulmonary and critical care patients

The American Thoracic Society has released a new official clinical policy statement on the treatment of fungal infections in adult pulmonary and critical care patients.

4 Jan 2011

Positron granted U.S. patents for quantum photodetectors

Positron Corporation, a leading molecular imaging company specializing in the field of nuclear cardiology, today announced it has received two U.S. patents for its proprietary quantum photodetectors.

24 Dec 2010

Results of proteomics study performed utilizing plasma samples from ADNI now available

The Foundation for the National Institutes of Health's Biomarkers Consortium announced today that the results of a proteomics study performed utilizing plasma samples from the Alzheimer's Disease Neuroimaging Initiative are ready to be shared with scientists worldwide for further analysis.

9 Dec 2010

PET/CT scan predicts, detects local recurrence after radiofrequency ablation

A study published in the December issue of The Journal of Nuclear Medicine identified positron emission tomography/computed tomography (PET/CT) scans as a potentially useful tool for predicting local recurrence in lung cancer patients treated with radiofrequency ablation (RFA). RFA, which uses localized thermal energy to kill cancer cells, is increasingly used as an alternative treatment for patients unable to undergo surgery or other therapies to treat lung cancer.

7 Dec 2010

Initial data from resminostat Phase II Hodgkin Lymphoma trial to be presented at 52nd ASH

4SC, a drug discovery and development company focused on autoimmune and cancer indications, today announced that initial safety and efficacy data from its ongoing Phase II Study with resminostat, a pan-Histone Deacetylase (HDAC) Inhibitor, in relapsed/refractory Hodgkin Lymphoma (HL) patients after high dose chemotherapy and autologous hematopoietic stem cell transplantation will be presented at the 52nd Annual Meeting of the American Society of Hematology (ASH) in Orlando, Florida, USA.

1 Dec 2010

New brain imaging technique can trace effects of SYN115 drug in Parkinson's disease

Neuroscientists using a new brain imaging technique could see an investigational drug for Parkinson's disease get into a patient's brain and affect blood flow in several key structures, an indicator the drug may be effective.

1 Dec 2010

Philips ushers new era in radiology science with Imaging 2.0 technology at RSNA annual meeting

This year at the 96th annual meeting of the Radiological Society of North America (RSNA) in Chicago, Royal Philips Electronics is ushering in a new era in radiology science with Imaging 2.0, a concept fueled by integration of technology, clinician and patient.

From Philips Healthcare 29 Nov 2010

Eckert & Ziegler enters exclusive sales agreement with Zyklotron for Fluorodeoxyglucose

Eckert & Ziegler Strahlen- und Medizintechnik AG, a company specializing in special compounds for the diagnosis and treatment of cancer, via its subsidiary company Eckert & Ziegler f-con Deutschland GmbH closed an exclusive sales agreement with the Karlsruhe-based ZAG Zyklotron AG for the regular delivery of Fluorodeoxyglucose (18F) (FDG). FDG is used in the context of the so called Positron Emission Tomography (PET) for the safe and quick recognition of even the smallest tumour foci.

23 Nov 2010

Positron Emission Tomography News and Research

Cell phone use and the brain: Study

Combined chemotherapy and radiation therapy effective against Hodgkin's lymphoma, in the short term

53 share a needle & HIV risk due to a clinic blunder

New facilities for developing imaging tests in PESA CNIC-Santander study inaugurated

FDA clears new mobile radiology application

PET imaging may play a role in early evaluation of vandetanib response in thyroid cancer

Taiwanese research team develops large-scale proactive cancer treatment system first-generation prototype

SNM commends FDA Advisory Committee recommendation for florbetapir approval

MedImmune announces MEDI-573 preclinical results against many solid tumors

No robust conclusions possible on advantages or disadvantages of PET

Bupropion and varenicline help curb cigarette craving

18F-FDG PET scans help evaluate cognitive dysfunction of pediatric fever-induced epilepsy

New ATS guidelines for treating fungal infection in adult pulmonary and critical care patients

Positron granted U.S. patents for quantum photodetectors

Results of proteomics study performed utilizing plasma samples from ADNI now available

PET/CT scan predicts, detects local recurrence after radiofrequency ablation

Initial data from resminostat Phase II Hodgkin Lymphoma trial to be presented at 52nd ASH

New brain imaging technique can trace effects of SYN115 drug in Parkinson's disease

Philips ushers new era in radiology science with Imaging 2.0 technology at RSNA annual meeting

Eckert & Ziegler enters exclusive sales agreement with Zyklotron for Fluorodeoxyglucose

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News